Management of colon and rectal cancers during COVID-19 pandemic: A clinical guideline (TUMS-CRC-CoV19 Guideline)

Keramati, Mohammad Reza; Behboudi, Behnam; Tafti, Seyed Mohsen Ahmadi; Kazemeini, Alireza; Keshvari, Amir; Salahshour, Faeze; Aghili, Mehdi; Alborzi, Foroogh; Aletaha, Najmeh; Babaei, Mohammad; Bangash, Mohammad Naeem; Ebrahimi‐Daryani, Nasser; Emami, Amir; Farhan, Farshid; Haddad, Peiman; Kalani, M. Yashar S.; Naseri, Amirhosein; Shahi, Farhad; Fazeli, Mohammad Sadegh

doi:10.47176/mjiri.34.128

Cited by 1 publication

(3 citation statements)

References 13 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The pandemic forced clinicians to make some modification like skipping endoscopic rectal ultrasound due to its invasive nature and increased risk for COVID-19 infection[ 40 , 55 , 62 - 66 ]. CEA levels should also be measured at presentation for adjunct diagnostic, prognostic and follow-up purposes.…”

Section: Diagnosis Of Colorectal Cancermentioning

confidence: 99%

“…The main aim of the operative treatment is to resolve the emergency situation. This can be achieved by creating a stoma and diverting fecal flow[ 66 ]. Definitive therapy has been associated with prolonged hospital stay and increased risk of COVID-19 infection.…”

Section: Management Of Colorectal Cancermentioning

confidence: 99%

“…In patients with perforation and peritonitis, irrigation of the peritoneal cavity and limited segmental resection of the perforated segment and proximal stoma are recommended[ 66 ]. Laparoscopic approach to surgical intervention has been encouraged by some surgeons as this is associated with less surgical trauma and encourages early discharge[ 9 ].…”

Section: Management Of Colorectal Cancermentioning

confidence: 99%

See 2 more Smart Citations

Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic

Akbulut¹,

Hargura²,

Garzali³

et al. 2022

WJCC

View full text Add to dashboard Cite

Management of colorectal cancer (CRC) was severely affected by the changes implemented during the pandemic, and this resulted in delayed elective presentation, increased emergency presentation, reduced screening and delayed definitive therapy. This review was conducted to analyze the impact of the coronavirus disease 2019 (COVID-19) pandemic on management of CRC and to identify the changes made in order to adapt to the pandemic. We performed a literature search in PubMed, Medline, Index Medicus, EMBASE, SCOPUS, Reference Citation Analysis ( ) and Google Scholar using the following keywords in various combinations: Colorectal cancer, elective surgery, emergency surgery, stage upgrading, screening, surveillance and the COVID-19 pandemic. Only studies published in English were included. To curtail the spread of COVID-19 infection, there were modifications made in the management of CRC. Screening was limited to high risk individuals, and the screening tests of choice during the pandemic were fecal occult blood test, fecal immunochemical test and stool DNA testing. The use of capsule colonoscopy and open access colonoscopy was also encouraged. Blood-based tests like serum methylated septin 9 were also encouraged for screening of CRC during the pandemic. The presentation of CRC was also affected by the pandemic with more patients presenting with emergencies like obstruction and perforation. Stage migration was also observed during the pandemic with more patients presenting with more advanced tumors. The operative therapy of CRC was altered by the pandemic as more emergencies surgeries were done, which may require exteriorization by stoma. This was to reduce the morbidity associated with anastomosis and encourage early discharge from the hospital. There was also an initial reduction in laparoscopic surgical procedures due to the fear of aerosols and COVID-19 infection. As we gradually come out of the pandemic, we should remember the lessons learned and continue to apply them even after the pandemic passes.

show abstract